SG11202103180QA - Methods and compositions for treating oral mucositis - Google Patents
Methods and compositions for treating oral mucositisInfo
- Publication number
- SG11202103180QA SG11202103180QA SG11202103180QA SG11202103180QA SG11202103180QA SG 11202103180Q A SG11202103180Q A SG 11202103180QA SG 11202103180Q A SG11202103180Q A SG 11202103180QA SG 11202103180Q A SG11202103180Q A SG 11202103180QA SG 11202103180Q A SG11202103180Q A SG 11202103180QA
- Authority
- SG
- Singapore
- Prior art keywords
- compositions
- methods
- oral mucositis
- treating oral
- treating
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 208000003265 stomatitis Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Zoology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862746943P | 2018-10-17 | 2018-10-17 | |
| PCT/US2019/056772 WO2020081839A1 (en) | 2018-10-17 | 2019-10-17 | Methods and compositions for treating oral mucositis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202103180QA true SG11202103180QA (en) | 2021-05-28 |
Family
ID=70281364
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202103180QA SG11202103180QA (en) | 2018-10-17 | 2019-10-17 | Methods and compositions for treating oral mucositis |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11123357B2 (https=) |
| EP (1) | EP3866810A4 (https=) |
| JP (1) | JP2022503733A (https=) |
| KR (1) | KR20210075968A (https=) |
| CN (1) | CN112839662A (https=) |
| AU (1) | AU2019361999A1 (https=) |
| BR (1) | BR112021006954A2 (https=) |
| CA (1) | CA3116157A1 (https=) |
| IL (1) | IL282100A (https=) |
| MX (1) | MX2021004396A (https=) |
| SG (1) | SG11202103180QA (https=) |
| WO (1) | WO2020081839A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12030908B2 (en) | 2017-03-10 | 2024-07-09 | Lakewood Amedex, Inc. | Antimicrobial compounds, compositions, and uses thereof |
| US11795192B2 (en) * | 2017-03-10 | 2023-10-24 | Lakewood Amedex, Inc. | Antimicrobial compounds, compositions, and uses thereof |
| WO2024129985A2 (en) * | 2022-12-14 | 2024-06-20 | Lakewood Amedex, Inc. | Antiviral compounds, compositions, and uses thereof |
| WO2025179296A1 (en) * | 2024-02-22 | 2025-08-28 | Lakewood Amedex, Inc. | Crystalline forms of nu-3 and uses thereof |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4421769A (en) | 1981-09-29 | 1983-12-20 | The Procter & Gamble Company | Skin conditioning composition |
| US5167950A (en) | 1991-03-28 | 1992-12-01 | S. C. Johnson & Son | High alcohol content aerosol antimicrobial mousse |
| WO1995024179A1 (en) | 1994-03-11 | 1995-09-14 | The Procter & Gamble Company | LOW pH, HYDROLYTICALLY STABLE, COSMETIC COMPOSITIONS CONTAINING ACIDIC ACTIVES |
| US7868162B2 (en) * | 1998-12-30 | 2011-01-11 | Lakewood-Amedex, Inc. | Antimicrobial and antiviral compounds and methods for their use |
| US6211349B1 (en) | 1998-12-30 | 2001-04-03 | Oligos Etc., Inc. | Protonated/acidified nucleic acids and methods of use |
| US20020032164A1 (en) | 1998-12-30 | 2002-03-14 | Dale Roderic M. K. | Antimicrobial compounds and methods for their use |
| US6211162B1 (en) | 1998-12-30 | 2001-04-03 | Oligos Etc. Inc. | Pulmonary delivery of protonated/acidified nucleic acids |
| CZ296576B6 (cs) | 1999-02-12 | 2006-04-12 | Sankyo Company Limited | Nukleosidový analog a oligonukleotidový analog a farmaceutický prostredek, sonda a primer s jeho obsahem |
| US6946118B1 (en) * | 1999-09-14 | 2005-09-20 | Orapharma, Inc. | Formulations for treating or preventing mucositis |
| US6156294A (en) | 1999-11-28 | 2000-12-05 | Scientific Development And Research, Inc. | Composition and method for treatment of otitis media |
| WO2003032909A2 (en) | 2001-10-18 | 2003-04-24 | Ilex Products, Inc. | Methods of treating skin with diphosphonate derivatives |
| AU2003230952A1 (en) * | 2002-05-21 | 2003-12-12 | Abbott Laboratories | Treatment of mucositis |
| CN1687100A (zh) * | 2005-04-05 | 2005-10-26 | 奥林格斯技术有限公司 | 修饰性核苷酸及其用途 |
| US8227431B2 (en) | 2008-03-17 | 2012-07-24 | Hetero Drugs Limited | Nucleoside derivatives |
| US8884000B2 (en) | 2010-02-17 | 2014-11-11 | Albert Einstein College Of Medicine Of Yeshiva University | Saporin-L1 inhibitors and uses thereof |
| EP2601205A2 (en) * | 2010-08-03 | 2013-06-12 | Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. | Guanine nucleotide derivatives for treating bacterial infections |
| AU2013264820A1 (en) * | 2012-05-23 | 2014-11-27 | Cellixbio Private Limited | Compositions and methods for treatment of mucositis |
| WO2014124430A1 (en) | 2013-02-11 | 2014-08-14 | Emory University | Nucleotide and nucleoside therapeutic compositions and uses related thereto |
| WO2015075406A1 (en) | 2013-11-19 | 2015-05-28 | Lipopeptide Ab | New treatment of chronic ulcers |
| EP3215126A1 (en) | 2014-10-30 | 2017-09-13 | Biomet Manufacturing, LLC | Methods of preventing surgical site infections |
| US10172786B2 (en) | 2014-12-16 | 2019-01-08 | Axim Biotechnologies, Inc. | Oral care composition comprising cannabinoids |
| US20200306119A1 (en) * | 2016-03-23 | 2020-10-01 | University Of Utah Research Foundation | Spinal traction device |
| JP6917078B2 (ja) * | 2017-03-10 | 2021-08-11 | レイクウッド アメディックス、インコーポレイテッド | 抗菌化合物、組成物、及びそれらの使用 |
| FI3638251T3 (fi) * | 2017-06-12 | 2024-04-29 | Lakewood Amedex Inc | Bisfosfosiinin geeliformulaatioita ja niiden käyttötapoja |
-
2019
- 2019-10-17 SG SG11202103180QA patent/SG11202103180QA/en unknown
- 2019-10-17 JP JP2021515005A patent/JP2022503733A/ja active Pending
- 2019-10-17 CN CN201980068116.XA patent/CN112839662A/zh active Pending
- 2019-10-17 KR KR1020217004939A patent/KR20210075968A/ko not_active Abandoned
- 2019-10-17 CA CA3116157A patent/CA3116157A1/en active Pending
- 2019-10-17 AU AU2019361999A patent/AU2019361999A1/en not_active Abandoned
- 2019-10-17 US US16/656,129 patent/US11123357B2/en not_active Expired - Fee Related
- 2019-10-17 BR BR112021006954-2A patent/BR112021006954A2/pt not_active Application Discontinuation
- 2019-10-17 WO PCT/US2019/056772 patent/WO2020081839A1/en not_active Ceased
- 2019-10-17 MX MX2021004396A patent/MX2021004396A/es unknown
- 2019-10-17 EP EP19874581.2A patent/EP3866810A4/en not_active Withdrawn
-
2021
- 2021-04-06 IL IL282100A patent/IL282100A/en unknown
- 2021-08-27 US US17/459,248 patent/US20210393666A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP3866810A1 (en) | 2021-08-25 |
| AU2019361999A1 (en) | 2021-02-25 |
| JP2022503733A (ja) | 2022-01-12 |
| US20210393666A1 (en) | 2021-12-23 |
| US11123357B2 (en) | 2021-09-21 |
| CN112839662A (zh) | 2021-05-25 |
| KR20210075968A (ko) | 2021-06-23 |
| EP3866810A4 (en) | 2022-07-27 |
| US20200121708A1 (en) | 2020-04-23 |
| IL282100A (en) | 2021-05-31 |
| MX2021004396A (es) | 2021-06-04 |
| CA3116157A1 (en) | 2020-04-23 |
| WO2020081839A1 (en) | 2020-04-23 |
| BR112021006954A2 (pt) | 2021-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL277079A (en) | Cartirin preparations and methods of use | |
| IL280134A (en) | Anti-CD112R preparations and methods | |
| IL276808A (en) | Preparations and methods for the treatment of cancer | |
| IL275626A (en) | Preparations and methods for surface treatment | |
| GB201905559D0 (en) | Composition and method | |
| SG11202009523UA (en) | Compositions and methods for long lasting disinfection | |
| IL285886A (en) | Preparations and methods for the treatment of laminopathy | |
| IL282100A (en) | Methods and compounds for treating oral mucositis | |
| SG11202009522TA (en) | Compositions and methods for long lasting disinfection | |
| IL271256A (en) | Preparations and methods for the treatment of teopathy | |
| SG11202104448WA (en) | Compositions and methods | |
| IL285796A (en) | Methods and preparations for the treatment of cancer | |
| SG11202100675YA (en) | Surface treatment compositions and methods | |
| IL290348A (en) | Surface treatment compositions and methods | |
| IL280413A (en) | Bismuth-thiol preparations and wound treatment methods | |
| IL282824A (en) | Preparations and methods for treating transient biofilms | |
| EP3836941A4 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF MUCOSITIS | |
| SG11202012055PA (en) | Methods and compositions for preventing or treating calciphylaxis | |
| GB201817444D0 (en) | Methods and compositions | |
| IL290325A (en) | Biopharmaceutical preparations and related methods | |
| IL269743A (en) | Methods and preparations for the treatment of disease related to the retina with CCR-3 inhibitor inventions | |
| GB201909542D0 (en) | Composition and method | |
| GB201819987D0 (en) | Methods and compositions | |
| GB201804092D0 (en) | Methods and compositions | |
| GB202214988D0 (en) | Compositions and methods for preventing or treating nephrolithiasis |